doi:https://doi.org/

References:

Spence J.D., Hachinski V. B Vitamins for Stroke Prevention: Interaction of Low Platelet Count and High Plasma Total Homocysteine. J Am Coll Cardiol 2018;71:2147—2148.
De Stefano V., Za T., Rossi E., et al. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica 2008;93:372—380.
Qin X., Li J., Spence J.D., et al. Folic acid therapy reduces the first stroke risk associated with hypercholesterolemia among hypertensive patients. Stroke 2016;47:2805—2812.
Mortensen M.B., Falk E. Primary prevention with statins in the elderly. J Am Coll Cardiol 2018;71:85—94.
Karhausen J.A., Smeltz A.M., Akushevich I., et al. Platelet counts and postoperative stroke after coronary artery bypass grafting surgery. Anesth Analg 2017;125:1129—1139.
Kertai M.D., Zhou S., Karhausen J.A., et al. Platelet counts, acute kidney injury, and mortality after coronary artery bypass grafting surgery. Anesthesiology 2016;124:339—352.
Spence J.D. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurology 2007;7:830—838.
Caplan L.R., Fisher M. The endothelium, platelets, and brain ischemia. Rev Neurol Dis 2007;4:113—121.
Deykin D. Thrombogenesis. N Engl J Med 1967;276:622—628.
Markus H.S., Droste D.W., Kaps M., et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial. Circulation 2005; 111:2233—2240.
Quinlivan E.P., McPartlin J., McNulty H., et al. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet 2002; 359:227—228.
Robertson J., Iemolo F., Stabler S.P., et al. Vitamin B12, homocysteine and carotid plaque in the era of folic acid fortification of enriched cereal grain products. CMAJ 2005;172:1569—1573.
Spence J.D., Yi Q., Hankey G.J. B vitamins in stroke prevention: time to reconsider. Lancet Neurol 2017;16:750—760.
Galan P., Kesse-Guyot E., Czernichow S., et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273.
Toole J.F., Malinow M.R., Chambless L.E., et al. Lowering plasma total homocysteine to prevent recurrent stroke, myocardial infarction, and death in ischemic stroke patients: results of the Vitamin Intervention for Stroke Prevention (VISP) Randomized Trial. JAMA 2004;291:565—575.
Vermeer S.E., Prins N.D., den Heijer T., et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215—1222.
Smith A.D., Refsum H., Bottiglieri T., et al. Homocysteine and dementia: an international consensus statement. J Alzheimers Dis 2018;62:561—570.
Toledo J.B., Arnold S.E., Raible K., et al. Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre. Brain 2013;136:2697—2706.
Azarpazhooh M.R., Avan A., Cipriano L.E., et al. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimers Dement 2018;14:148—156.
Jin Y.P., Di Legge S., Ostbye T., et al. The reciprocal risks of stroke and cognitive impairment in an elderly population. Alzheimers Dement 2006;2:171—178.